Focus-X Therapeutics

Sammamish, United States

Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the radiopharmaceutical pipeline.

Jan 2022

Venture - Series Unknown

Biotechnology

Top Investors

Viva BioInnovator Xiamen Changrong Investment Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Focus-X Therapeutics

Who are Focus-X Therapeutics's investors?

Focus-X Therapeutics's investors include Viva BioInnovator, Xiamen Changrong Investment Management.

Where is Focus-X Therapeutics headquartered?

Focus-X Therapeutics is headquartered in Sammamish, United States.

What does Focus-X Therapeutics do?

Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the radiopharmaceutical pipeline.

What stage is Focus-X Therapeutics at?

Focus-X Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2022.

MLA

"Focus-X Therapeutics — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/focus-x-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2022). Focus-X Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/focus-x-therapeutics

Wikipedia (cite web)

{{cite web |title=Focus-X Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/focus-x-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K